A Comprehensive Guide to Clinical Trial Patient Recruitment
Arguably, one of the most important elements to clinical research is patient recruitment. For a new medicine to come to market, it must withstand rigorous…
Why Clinical Research Needs Its Own Jedi Council
A look at how IRBs bring wisdom, balance and protection to the research galaxy In a galaxy not so far away—our own—clinical research is advancing…
I Will Survive: How the IRB Protects Participants From Research Gone Wrong
In the world of clinical research, participant safety isn’t just a priority, it’s the priority. Every research study comes with potential risks, and while scientific…
Avoid These IRB Submission Mistakes to Speed Up Approval
Historically, IRB submissions can be daunting – strange forms, specific questions and lots of acronyms. We know that you have tight turnaround times and numerous…
Should Sponsors Cover 100% of Clinical Trial Costs? – An IRB Perspective
In the United States, most clinical trials are conducted with funding provided by a government agency, industry or other sponsor. Typically, these sponsors cover some…
Clinical Trial Participant Rights and the Importance of Ethical IRB Review
As the number and complexity of clinical trials continue to grow, so does the imperative to ensure that participants are fully informed about the risks…
Gene Therapy in Action: CTLA4 Haploinsufficiency
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
Gene Therapy in Action: Fabry Disease
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
Gene Therapy In Action: Amyotrophic Lateral Sclerosis (ALS)
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
![Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])](https://sabaiglobal.com/wp-content/uploads/2024/09/sab-wp2-768x508.png)
Gene Therapy in Action: Hunter Syndrome (Mucopolysaccharidosis Type II [MPSII])
Gene Therapy in Action is a digital publication casting an important spotlight on rare diseases and cancers. This series highlights the increasingly critical role of…
